Pick a time period -
No more available filters You need to apply a filter before selecting newsroom

Use our filters to get your customized news. Save and subscribe to as many filters as you want, get the news that YOU are interested in right in your mailbox, RSS feed or in your personalized dashboard. Share your stories, news, multimedia and pressreleases and get a wider audience with news.cision.com.

#24-136 Delisting of Derivatives from NGM

Information about certain derivatives that will be delisted from NGM.For more details, see attached files. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for

#24-135 Listing of Derivatives at NGM

Information about various derivatives that will be listed at NGM.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden, Norway, Denmark and Finland. The exchange is a wholly-owned subsidiary of Boerse Stuttgart, the leading retail exchange in Germany. NGM offers a complete marketplace for exchange traded products and provides a complete platform for companies

#24-134 Changes to certain Derivatives at NGM

Effective from April 17[th], 2024, the previous short name of Valour Short BTC SEK with ISIN CH1149139649 has been updated to VALOUR SHORT BTC SEK accompanied by a corresponding change in the long name to Valour Short Bitcoin (SBTC) SEK. The change in short- and long name will be applicable from 2024-04-17.For more details, see attached file. For further information concerning this NGM notice please contact NGM Listing department on listings@ngm.se. Nordic Growth Market NGM AB About NGMNordic Growth Market NGM AB (NGM) is an authorized stock exchange with operations in Sweden,

ANNOUNCEMENT FROM THE EXTRAORDINARY GENERAL MEETING OF PHARMACOLOG I UPPSALA AB ON APRIL 16, 2024

Extraordinary General Meeting in Pharmacolog i Uppsala AB, reg. no. 556723-6418, (the "Company"), took place today, Wednesday, April 16, 2024, at 11.00 am at Clarion Hotell Gillet in Uppsala.All decisions were made in accordance with the Board's previously published proposal and with the required majority. Decisions new articles of association for the company It was resolved to change § 1 Company name in the articles of association to: "The company's company name is Perpetua Medical AB (publ). The company is public." In the event that the company name, for any reason, is not approved

ExpreS2ion changes dates for the annual general meeting and the publication of the annual report for 2023

Hørsholm, Denmark, 16 April 2024 – ExpreS2ion Biotech Holding AB ("ExpreS2ion" or the "Company") announces that the Board of Directors of ExpreS2ion has resolved to postpone the Company's annual general meeting and consequently also the publication of the annual report for 2023 due to administrative and practical reasons.The new date for the annual general meeting is 30 May 2024 and the new date for publication of the annual report for 2023 is 8 May 2024. An updated financial calendar is available on the Company's website, www.expres2ionbio.com. Certified AdviserSvensk

Notice to attend the Annual General Meeting of Sivers Semiconductors AB (publ)

The shareholders of Sivers Semiconductors AB (publ) (the “Company”), reg. no. 556383-9348, are hereby invited to attend the Annual General Meeting to be held on Wednesday, 15 May 2024 at 4.00 pm at the Company’s premises at Torshamnsgatan 48 in Kista, Sweden.Notification to attend etc. Shareholders who wish to attend the Annual General Meeting must · be recorded in the share register kept by Euroclear Sweden AB no later than on Monday, 6 May 2024; and · notify the Company their intention to participate no later than Wednesday, 8 May 2024, via mail to the address Setterwalls

Stora Enso Oyj: Notification of Change in Holdings according to Chapter 9, Section 10 of the Finnish Securities Markets Act (15 April 2024)

STORA ENSO OYJ STOCK EXCHANGE RELEASE 16 April 2024 at 17:30 EESTStora Enso Oyj has received a notification pursuant to chapter 9, section 5 of the Securities Market Act from BlackRock, Inc on 16 April 2024. On 15 April 2024, BlackRock's total holding, including holding through financial instruments, in Stora Enso’s shares fell below the 5 percent threshold. +----------------+--------------+-----------------------------+---------------+|  |% of shares |% of shares and voting rights|Total of both || |and voting |through financial instruments|in % (

Boeing makes its largest purchase of blended Neste MY Sustainable Aviation Fuel to be supplied by EPIC Fuels and Avfuel

Neste Corporation, News, 16 April 2024 Photo: Boeing ecoDemonstrator in flight. Source: BoeingBoeing has agreed to purchase 7.5 million gallons (over 22,700 tons) of blended Neste MY Sustainable Aviation Fuel™  in 2024 to support its U.S. Commercial Airplanes business operations in reducing its greenhouse gas (GHG) emissions. The volume of Neste’s sustainable aviation fuel (SAF) is part of Boeing’s total purchase of 9.4 million gallons of blended SAF, representing Boeing’s largest annual SAF purchase to date, 60% more than in 2023.

Notice of Annual General Meeting in Fractal Gaming Group AB (publ)

The shareholders of Fractal Gaming Group AB (publ), Reg. No. 559080-2970 (“Fractal Gaming Group”), with its registered office in Stockholm, Sweden, are hereby summoned to the Annual General Meeting to be held on Tuesday 21 May 2024 kl 10:00 at Victor Hasselblads Gata 16A, Västra Frölunda. Right to attend and notification Participation in the meeting room Anyone who wishes to attend the meeting in person or by proxy must (i) be listed as a shareholder in the share register prepared by Euroclear Sweden AB regarding the conditions on May 13, 2024, and (ii) register by mail to Victor

Notification according to chapter 9, section 5 and 6 of the Securities Market Act: BlackRock Inc.’s holding in Metso

Metso Corporation’s stock exchange release on April 16, 2024, at 4:45 p.m. EESTMetso Corporation has received a notification, pursuant to Chapter 9, Section 5 and 6 of the Finnish Securities Markets Act, about a change in the shareholding of BlackRock, Inc. On April 15, 2024, BlackRock's holding in Metso’s shares fell below the 5 percent threshold and amounted to 41,159,143 shares or 4.96 percent of total shares and votes. BlackRock's holding through financial instruments in Metso amounted to 1,032,083 shares, which corresponds to 0.12 percent of the total amount of Metso’s shares. On

Publication of 2023 annual report in ESEF (errata corrigendum)

Reference is made to the company announcement published by Catena Media plc (the “Company”) on 26 March 2024 (ref. CAM 136) wherein the Company announced the publication of its 2023 annual report (the “March Announcement”). The Company would like to announce that the European Single Electronic Format (“ESEF”) compliant version of its 2023 annual financial report has today been uploaded on the Officially Appointed Mechanism operated by the Malta Stock Exchange. As mentioned in the March Announcement, the ESEF-compliant report is also available on the Company’s website

Dolphin Drilling AS - Notice of extraordinary general meeting

(Oslo, 16 April 2024) Dolphin Drilling AS ("Dolphin Drilling", ticker: DDRIL) – An extraordinary general meeting of Dolphin Drilling AS will be held on 30 April 2024 at 10:00 hours (CEST) as a virtual meeting. The notice of the extraordinary general meeting is attached to this release. The notice will be sent to all registered shareholders on 16 April 2024. The notice and all other documents related to the items to be considered at the extraordinary general meeting will, on the same date, be available on Dolphin Drilling's website https://www.dolphindrilling.com/investor-relations and

Diös Fastigheter AB (publ) Annual General Meeting 2024

Diös Fastigheter (publ) (“Diös”) has today, 16 April 2024, held its Annual General Meeting (“AGM”) at Diös Headquarters, Hamngatan 14, Östersund, Sweden. Following decision were taken by the AGM: · to determine that no dividend will be paid for the 2023 financial year, · to re-elect the Board of Directors: Bob Persson, Ragnhild Backman, Peter Strand, Erika Olsén and Per-Gunnar Persson,    · to re-elect Bob Persson as Chairman of the Board, · the Board of Directors’ remuneration to be SEK 1,260,000 in total, · to elect the registered audit firm Deloitte AB, with Kent

Cyclyx Announces Expansion of Innovative 10to90 All-Plastic Bag It & Bring It Collection Program in City of Houston to Divert Plastic Waste from Landfill

Five new locations in Houston will increase the ability to divert more plastic from landfill, ultimately helping to increase the recyclability of post-use plastics  HOUSTON, TX and PORTSMOUTH, NH, USA, April 16, 2024 – Cyclyx International , a post-use plastic innovator that develops solutions to unlock plastic’s recycling potential, announces the expansion of its 10to90[®] all-plastic Bag It & Bring It collection program to five new locations in Houston. Sponsored by the City of Houston , ExxonMobil ,

The Nomination Committee's proposal for the election of Board members and Chairperson of the Board in BioArctic AB

Stockholm April 16, 2024 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) hereby announces that the Nomination Committee for BioArctic AB (publ) presents the following proposals regarding the resolution on the number of board members and the election of board members and Chairperson of the Board at the Annual General Meeting on May 22, 2024.The Nomination Committee proposes that the board shall consist of seven members, without deputies. The Nomination Committee proposes that Eugen Steiner, Cecilia Edström, Pär Gellerfors, Lars Lannfelt, Lotta Ljungqvist and Mikael Smedeby be re-elected

Veidekke: Notice of Annual General Meeting 2024

Veidekke ASA’s Annual General Meeting will be held Tuesday, 7 May 2024 at 18:00 (CET) The Annual General Meeting will be conducted as a hybrid meeting, where shareholders can choose to attend online or in person. For in person attendance, the location of the meeting is Veidekke’s headquarters at Skabos vei 4, Oslo. Voting will take place electronically via Lumi AGM for all attendees. The meeting will be conducted in Norwegian. For online attendance, no pre-registration is required, but attendees must be logged in before the meeting starts. Login and registration opens at 17:00 (CET).

Katalysen Ventures publishes revised 2023Q4 Report following bankruptcy declaration by Payer Financial Services

Katalysen Ventures AB (publ) ("Katalysen", the "Company") hereby publishes a revised 2023Q4 report, which is available immediately on the Company's website and as an attachment to this press release.This publication is the result of the recent declaration of bankruptcy by Payer Financial Services AB ("Payer"), which has necessitated a full write-down (SEK 9.2M, including loans) of Payer's assets in Katalysen's books and in the 2023 Annual Report. The valuation of Payer in the Company's portfolio valuation has also been adjusted down from SEK 9.0 million to SEK 0.

Diagonal Bio AB publish – White paper

Diagonal Bio’s platforms using an 8-parallel test format, show overall Accuracy of 99.6 %, Sensitivity of 100 %, and Specificity of 99.5 %.Diagonal Bio publishes its latest white paper describing the technology and specifications of its the LAMPlify® and Panviral® platforms for pathogen detection in a user-centric, 8-parallel test format. The platform technology taps into the ultra-fast speed and convenience of the Loop-mediated Isothermal Amplification (LAMP), and the specificity and robustness of Electrochemical detection. As a part of Diagnostic Performance Evaluation of the LAMPlify®

Read original

Notification of major holding in Kindred Group plc

Kindred Group plc (Kindred) hereby announces that it, on 4 April 2024, has received a notification of major holding from JPMorgan Chase & Co, a company with its registered office in Wilmington, Delaware, USA. The notification refers to a decreased number of shares and voting rights in Kindred held by JPMorgan Chase & Co.According to the notification, JPMorgan Chase & Co holds 4.82% of the shares and voting rights in Kindred as of 2 April 2024. The relevant chain of controlled undertakings can be found in the notification, of which a copy can be found on Kindred’s website: https://www.

ExpreS2ion announces completion of GLP safety study for ES2B-C001 (HER2-VLP) breast cancer vaccine candidate

Hørsholm, Denmark, 16 April 2024 – ExpreS2ion Biotech Holding AB’s affiliate ExpreS2ion Biotechnologies ApS (“ExpreS2ion") is pleased to announce the completion of the final report for the Good Laboratory Practice (GLP) safety study in non-human primates of the ES2B-C001 (HER2-VLP) breast cancer vaccine candidate.This significant milestone marks an important step towards enabling a clinical trial application. The Company is currently focusing on Good Manufacturing Practice (GMP) production and designing the Phase I clinical trial, with the aim to initiate the Phase I trial within the next

BerGenBio ASA: Final results for the last exercise period for warrants issued in connection with rights issue

NOT FOR RELEASE, PUBLICATION OR DISTRIBUTION, DIRECTLY OR INDIRECTLY, IN CANADA, JAPAN, AUSTRALIA OR THE UNITED STATES, OR ANY OTHER JURISDICTION IN WHICH SUCH RELEASE, PUBLICATION OR DISTRIBUTION WOULD BE UNLAWFUL. THIS ANNOUNCEMENT DOES NOT CONSTITUTE AN OFFER OF ANY OF THE SECURITIES DESCRIBED HEREIN. PLEASE SEE THE IMPORTANT NOTICE AT THE END OF THIS ANNOUNCEMENT. Bergen, Norway, 16 April 2024 - Reference is made to the stock exchange announcement published by BerGenBio ASA (the "Company") 2 April 2024 regarding the start of the last exercise period for the warrants (the "Warrants")

TATAA Biocenter Achieves GLP Accreditation for qPCR and dPCR

Approval enables regulated analysis services for cell and gene therapies. This important milestone for TATAA Biocenter provides customers access to safety testing, accelerating the transition of promising therapies from laboratory research and preclinical testing to clinical applications.TATAA Biocenter announced today that it has been awarded Good Laboratory Practice (GLP) accreditation. The accreditation represents a crucial step in the company’s strategic progression into a market leading molecular analysis contract research organization (CRO) expediting biopharmaceutical innovations in

There are no items matching the current filter
There are no more items matching the current filter
Back to top